Thomas Botton
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic potential of targeting mitophagy in cancer
Journal: Medecine sciences : M/S
Published: November 19, 2025
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.
Journal: Experimental hematology & oncology
Published: July 09, 2025
Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies.
Journal: Clinical and translational medicine
Published: June 20, 2024
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
Journal: ChemMedChem
Published: September 13, 2023
Comment on 'Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy'.
Journal: Journal of clinical pathology
Published: December 06, 2019
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
Journal: Cancer cell
Published: August 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026